Regulation

Analysis: Bad data - A risky business for insurers?

Data is everywhere: good data, partial data, valuable data, bad data. Insurers need data to measure and price risks but do they take enough care in assessing the quality and provenance of the data they are using and are their processes sufficiently…

This month: Seeking the right fit

I’m a fan of making sure stuff is the right fit - I make a point of trying on new outfits in my own home with accessories and shoes to make sure it all works for me. I also test drove my new car a few times to check it was what I wanted. Aon, however,…

Blog: Opioid epidemic - The pain persists

Britain is in danger of replicating the painkiller epidemic that has ravaged the US. Dorothy Flower, partner, and Emma Kislingbury, associate at RPC, explore how this might impact pharmaceutical companies, medical practitioners, healthcare providers, and…

Q&A: Richard Coleman, Collinson

With increased regulation and Brexit travel insurance is facing an interesting time, Post caught up with Richard Coleman, European director at Collinson, who talked to us about his thoughts on market developments in 2019.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here